| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/24/2002 | US20020156253 Nucleotide sequences coding polypeptides for use in the treatment of pain |
| 10/24/2002 | US20020156252 Novel Stra6 polypeptides |
| 10/24/2002 | US20020156251 Fusion protein for use in the treatment and prevention of viral diseases |
| 10/24/2002 | US20020156250 Purification of heat shock protein complexes; obtain sample containing peptides, polypeptides and proteins, incubate with chaperone proteins, expose to column, elute amd recover complexes |
| 10/24/2002 | US20020156249 Endoderm, cardiac and neural inducing factors-oligonucleotides for expressing murine frazzled (Frzb-1) protein |
| 10/24/2002 | US20020156246 15625 receptor, a novel G-protein coupled receptor |
| 10/24/2002 | US20020156245 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and differentiation, nervous system, stroke and drug addiction, bone, gut, skin, urogenital, ulcer, pancreas and diabetic disorders |
| 10/24/2002 | US20020156244 Adipocyte complement related protein zacrp13 |
| 10/24/2002 | US20020156243 Adipocyte-specific protein homologs |
| 10/24/2002 | US20020156242 Cell surface molecule mediating cell adhesion and signal transmission |
| 10/24/2002 | US20020156241 Leukotriene receptor |
| 10/24/2002 | US20020156239 Tryrosine kinases receptor protein for use in the prevention and treatment of of nervous system, inflammatory and tumor defects |
| 10/24/2002 | US20020156238 Polypeptide for use in the prevention, detection and treatment of cancer, immunological, autoimmune, inflammatory, cardiovascular, metabolic and nervous system disorders |
| 10/24/2002 | US20020156236 Peptide for use in the treatment of cell proliferative disorders |
| 10/24/2002 | US20020156235 Generating preferential oligomers; generate oligomer, deprotect, expose to phosphorous, oxidize, expose to sulfur, cleave, recover product |
| 10/24/2002 | US20020156234 Obtaining insulin precursors; generate suspension of insulin and cysteine hydrochloride, heat, recover insulin precursors |
| 10/24/2002 | US20020156123 Novel pharmaceutical compositions for modulating angiogenesis |
| 10/24/2002 | US20020156044 Use of EXT genes for the treatment of cancer and other diseases |
| 10/24/2002 | US20020156039 Sal2 has a tumor suppressive effect; Sal2 may also be used as an anti-viral agent that interferes with the ability of a DNA tumor virus to replicate in a cell |
| 10/24/2002 | US20020156036 Expression vector encoding a fusion protein with segments of a region which binds to an epitope or fragment and fragment or whole proteins that can cross the blood brain barrier |
| 10/24/2002 | US20020156035 NET-4 is a member of the tetraspan transmembrane receptor family; antisense molecules, ribozymes, antibodies and antibody fragments for reductin NET-4 gene expression or activity; antitumor agents |
| 10/24/2002 | US20020156034 Chemokine receptor antagonists, including peptide antagonists of CXC chemokine receptor 4 (CXCR4) for use in the treatment of hematopoietic (stem/progenitor) cells; mobilize the these cells from marrow to peripheral blood; gene therapy |
| 10/24/2002 | US20020156031 A DNA segment comprising a protein coding region encoding an Osterix polypeptide; gene therapy; osteoporosis; recombinant Osterix polypeptide |
| 10/24/2002 | US20020156014 Human neurosecretory proteins |
| 10/24/2002 | US20020156013 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 10/24/2002 | US20020156012 Polypeptide containing the JAB subunit or the JAM domain has peptidase activity, e.g., isopeptidase activity. |
| 10/24/2002 | US20020156011 One or more colon tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, may comprise an antigen presenting cell that expresses a colon tumor protein |
| 10/24/2002 | US20020156009 Novel interleukin - 1 Hy2 materials and methods |
| 10/24/2002 | US20020156008 Agents for blocking T cell mediated immune reactions |
| 10/24/2002 | US20020156007 Apolipoprotein analogues |
| 10/24/2002 | US20020156006 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/24/2002 | US20020156002 32620, a novel human sodium-sugar symporter family member and uses thereof |
| 10/24/2002 | US20020156001 Novel fibroblast growth factor ( FGF23) and methods for use |
| 10/24/2002 | US20020156000 Inhibiting NF-kappa B-dependent target gene expression in a cell. |
| 10/24/2002 | US20020155998 Erythropoietin analog-human serum albumin fusion |
| 10/24/2002 | US20020155996 Recombinant alpha-fetoprotein for treating cancers |
| 10/24/2002 | US20020155995 Haptoglobin-haemoglobin complex or a part thereof or a mimic thereof being operably linked to a substance; capable of binding a CD163 receptor and/or a CD163 receptor variant. |
| 10/24/2002 | US20020155992 Paclitaxel, epipodophyllotoxin, decetaxel, topotecan, and podophyllotoxin covalently conjugated to a polypeptide drug carrier having 50-90% by weight glutamic acid; inproved solubility |
| 10/24/2002 | US20020155989 Protein nucleic acid molecules |
| 10/24/2002 | US20020155987 Isolated endostatin, especially approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII |
| 10/24/2002 | US20020155610 High-efficiency wild-type-free AAV helper functions |
| 10/24/2002 | US20020155608 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions |
| 10/24/2002 | US20020155607 Multifunctional molecular complexes for gene transfer to cells |
| 10/24/2002 | US20020155605 Expression vector for use as tool in controlling gene expression in plants |
| 10/24/2002 | US20020155604 Compositions and methods for regulating lymphocyte activation |
| 10/24/2002 | US20020155602 Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors |
| 10/24/2002 | US20020155597 In vivo production and delivery of erthropoietin or insulinotropin for gene therapy |
| 10/24/2002 | US20020155581 Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens |
| 10/24/2002 | US20020155580 Recombinant aav vectors for gene therapy of hemophilia a |
| 10/24/2002 | US20020155578 Streptavidin-binding peptides and uses thereof |
| 10/24/2002 | US20020155577 Compound for use in the treatment of parkinson's disease |
| 10/24/2002 | US20020155576 Compound for use in the treatment and prevention of cell proliferation disorders |
| 10/24/2002 | US20020155572 Peptide for use in diagnosis and treatment of alzheimier's disease |
| 10/24/2002 | US20020155569 Regulation of gene expression through manipulation of mRNA splicing and its uses |
| 10/24/2002 | US20020155564 Cloning of a high growth gene |
| 10/24/2002 | US20020155563 Nucleotide sequences coiding polypeptide for use in the diagnosis, prevention and treatment of tumors and immunological defects |
| 10/24/2002 | US20020155561 Mammalian disulfide core protein-4 |
| 10/24/2002 | US20020155557 Nucleotide sequences which code for the rpsL gene |
| 10/24/2002 | US20020155554 Nucleotide sequences coding polypeptide for use in generation of amino acids for use in human and animal medicines and nutrients |
| 10/24/2002 | US20020155553 Human vesicle binding protein |
| 10/24/2002 | US20020155552 "prionins", highly specific markers for noninvasive pre-symptomatic detection of tse diseases, and targets for therapeutic reagents to prevent and control tse diseases in animals and humans |
| 10/24/2002 | US20020155551 Process for the fermentative preparation of L-threonine |
| 10/24/2002 | US20020155549 Isolated yeast promoter sequence and a method of regulated heterologous expression |
| 10/24/2002 | US20020155547 Polypeptide for use in the treatment of cancer, hepatitis, multiple sclerosis, fibrosis, inflammatory or autoimmune diseases, cancers and viral diseases |
| 10/24/2002 | US20020155546 Adipocyte complement related protein ZACRP12 |
| 10/24/2002 | US20020155545 Chemokines expressed in pancreas |
| 10/24/2002 | US20020155544 Treatment of diabetes with synthetic beta cells |
| 10/24/2002 | US20020155543 Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders |
| 10/24/2002 | US20020155542 Inhibitors for suppressing the activity of proteins displaying CIITA activity, methods for their identification and pharmaceutical compositions |
| 10/24/2002 | US20020155539 Calcium channel polynucleotides, polypeptides, and antibodies |
| 10/24/2002 | US20020155538 Novel endothelial growth factor |
| 10/24/2002 | US20020155537 Method for making heteromultimeric polypeptides |
| 10/24/2002 | US20020155534 SBHWSB2: a new member of the WD40 SOCS box family |
| 10/24/2002 | US20020155533 PACAP receptor protein, method for preparing said protein, and use thereof |
| 10/24/2002 | US20020155532 Method of producing biologically active human acidic fibroblast growth factor and its use in promotiong angiogenesis |
| 10/24/2002 | US20020155531 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 10/24/2002 | US20020155528 Regulation of human CysLT2-like GPCR protein |
| 10/24/2002 | US20020155527 Nucleotide sequences coding membrane protein for use in the treatment of tumors |
| 10/24/2002 | US20020155526 Novel secreted immunomodulatory proteins and uses thereof |
| 10/24/2002 | US20020155525 Expression vector for use in generation of preferential polypeptides in culture |
| 10/24/2002 | US20020155519 Human blood bacterium |
| 10/24/2002 | US20020155512 EDG: modulators of lymphocyte activation and migration |
| 10/24/2002 | US20020155506 Human IL-1 epsilon DNA and polypeptides |
| 10/24/2002 | US20020155505 Methods for ligand discovery |
| 10/24/2002 | US20020155500 Detecting modulators of receptor binding activity; obtain sample containing receptor protein, incubate with modulator, monitor and evaluate protein binding |
| 10/24/2002 | US20020155498 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof |
| 10/24/2002 | US20020155479 Expression cloning method |
| 10/24/2002 | US20020155473 Detect gene expression pattern associated preferential genetic disorders; obtain sample containing nucleotide sequences, incubate with solid support, monitor expression patterns, compare to control, classify genetic disorder |
| 10/24/2002 | US20020155472 Detecting gene expression pattern of transport proteins; obtain nucleotide sequences, incubate with solid support, detect hybridization, compare to control expression pattern |
| 10/24/2002 | US20020155471 Compounds for therapy and diagnosis and methods for using same |
| 10/24/2002 | US20020155468 Ovarian tumor antigen and methods of use therefor |
| 10/24/2002 | US20020155464 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention, classification, imaging and treatment of cancer |
| 10/24/2002 | US20020155463 Prostate polynucleotides and uses |
| 10/24/2002 | US20020155455 Marker compound for use as visualization tool in genetic engineering |
| 10/24/2002 | US20020155452 Fusion of jAZF1 and jjAZ1 genes in endometrial stromal tumors |
| 10/24/2002 | US20020155450 Screening human sample for polymorphisms; obtain mammalian sample, screen nucleotide sequences, detect polymorphism, evaluate for brain disorders |
| 10/24/2002 | US20020155447 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 10/24/2002 | US20020155446 Very low density lipoprotein receptor polymorphisms and uses therefor |
| 10/24/2002 | US20020155444 Neuronal protein for use in the treatment of psychiatric, nervous system, sleep and fertility disorders |
| 10/24/2002 | US20020155443 Metal compound for use as tool in alkylation, cleavage, metalization, hydrolysis, or crosslinking; for use in treatment of cancer |